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1660Background: Counterpulsation with an intra-aortic balloon pump (IABP) has not achieved the same success or
clinical use in pediatric patients as in adults. In a pediatric animal model, IABP efficacy was investigated to
determine whether IABP timing with a high-fidelity blood pressure signal may improve counterpulsation ther-
apy versus a low-fidelity signal.
Methods: In Yorkshire piglets (n ¼ 19; weight, 13.0  0.5 kg) with coronary ligation-induced acute ischemic
left ventricular failure, pediatric IABPs (5 or 7 mL) were placed in the descending thoracic aorta. Inflation and
deflation were timed with traditional criteria from low-fidelity (fluid-filled) and high-fidelity (micromanometer)
blood pressure signals during 1:1 support. Aortic, carotid, and coronary hemodynamics were measured with
pressure and flow transducers. Myocardial oxygen consumption was calculated from coronary sinus and arterial
blood samples. Left ventricular myocardial blood flow and end-organ blood flow were measured with micro-
spheres.
Results: Despite significant suprasystolic diastolic augmentation and afterload reduction at heart rates of 105
3 beats per minute, left ventricular myocardial blood flow, myocardial oxygen consumption, the myocardial ox-
ygen supply/demand relationship, cardiac output, and end-organ blood flow did not change. Statistically signif-
icant end-diastolic coronary, carotid, and aortic flow reversal occurred with IABP deflation. Inflation and
deflation timed with a high-fidelity versus low-fidelity signal did not attenuate systemic flow reversal or improve
the myocardial oxygen supply/demand relationship.
Conclusions: Systemic end-diastolic flow reversal limited counterpulsation efficacy in a pediatric model of
acute left ventricular failure. Adjustment of IABP inflation and deflation timing with traditional criteria and a
high-fidelity blood pressure waveform did not improve IABP efficacy or attenuate flow reversal. End-
diastolic flow reversal may limit the efficacy of IABP counterpulsation therapy in pediatric patients with tradi-
tional timing criteria. Investigation of alternative deflation timing strategies is warranted. (J Thorac Cardiovasc
Surg 2014;147:1660-7)Counterpulsation with an intra-aortic balloon pump (IABP)
is the most common mechanical circulatory support strat-
egy for a variety of cardiac pathologies in adults.1 Yet,
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The Journal of Thoracic and Cardiovascular Surclinical use.2 Differences between adult and pediatric anat-
omy and physiology may limit the efficacy of IABP therapy
in neonates, infants, and children.
In this study, we examined IABP counterpulsation in a
pediatric model of acute ischemic left ventricular failure.
We tested the hypothesis that the efficacy of pediatric
IABP therapy is improved with a high-fidelity (microman-
ometer) rather than a traditional low-fidelity (fluid-filled)
arterial blood pressure signal used to adjust IABP inflation
and deflation timing.METHODS
All animals received humane care and were handled in accordance with
the Guide for the Care and Use of Laboratory Animals (National Research
Council, 1996). Experimental procedures followed animal study protocols
approved by the University of Louisville (Louisville, Ky) Institutional An-
imal Care and Use Committee.
Experimental Design
Piglets (n ¼ 19; weight, 13.0 0.5 kg) were instrumented surgically to
determine aortic, carotid, and coronary artery hemodynamics. Myocardial
oxygen consumption (MVO2) was calculated from coronary sinus and arte-
rial blood gas data. Left ventricular myocardial blood flow and regionalgery c May 2014
Abbreviations and Acronyms
AoF ¼ aortic flow
AoP ¼ aortic pressure
bpm ¼ beats per minute
IABP ¼ intra-aortic balloon pump
LAD ¼ left anterior descending
LADF ¼ LAD flow
LAP ¼ left atrial pressure
LVP ¼ left ventricular pressure
MVO2 ¼ myocardial oxygen consumption
Bartoli et al Evolving Technology/Basic Scienceend-organ blood flow were determined with neutron-activated 15-mm mi-
crospheres. Sequential coronary ligation was performed to induce acute
ischemic left ventricular failure. A pediatric IABP was placed in the de-
scending thoracic aorta.
In each animal, hemodynamic waveforms (15-second data epochs),
blood gases, and end-organ blood flows were measured at steady state dur-
ing the following experimental test conditions: (1) normal baseline (IABP
off), (2) coronary ligation-induced left ventricular failure (IABP off), (3)
IABP support with timing adjusted to the arterial blood pressure waveform
acquired with a low-fidelity (<20-Hz response) fluid-filled catheter in the
radial artery, and (4) IABP support with timing adjusted to the arterial pres-
sure waveform acquired with a high-fidelity (<5-kHz response) microman-
ometer pressure transducer in the aortic root. Measurements were recorded
during 1:1 counterpulsation support in which each aortic valve closure
initiated rapid balloon inflation and each end diastole initiated rapid
balloon deflation.
Of note, an aortic root pressure waveform transduced by a high-fidelity
catheter results in a more precise waveform morphology with a more
pronounced dicrotic notch, less signal gain, and less phase distortion.3
Consequently, a high-fidelity signal was presumed to enable more accurate
inflation and deflation timing of the IABP.E
T
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SSurgical Preparation
Animals were fasted, preanesthetized with intramuscular ketamine (30
mg/kg) and acepromazine (0.2 mg/kg), and anesthetized with isoflurane
(1.5%-3%) and room air. A left lateral thoracotomy was performed, and
the left and right carotid artery and jugular vein were exposed through
neck incisions. A single-tip high-fidelity micromanometer catheter (2.5
Fr, SPR-524; Millar Instruments, Houston, Tex) was placed in the left
atrium. A dual-tip high-fidelity micromanometer catheter (5 Fr, SPC-
721;Millar Instruments) was advanced retrograde from the ascending aorta
into the left ventricle. Transit-time ultrasonic flow probes (T205; Tran-
sonics, Ithaca, NY) were placed around the aortic root, left carotid artery,
and left anterior descending (LAD) coronary artery to measure volumetric
blood flows. Sampling catheters were introduced into the coronary sinus
via the hemiazygous vein, pulmonary artery, and right carotid artery to
sample blood and measure blood gases. An infusion catheter was intro-
duced into the left atrium for serial injections of microspheres during
each experimental test condition to determine end-organ blood flows
throughout the body.4 A blood-sampling catheter was introduced into the
right femoral artery for simultaneous withdrawal of a microsphere refer-
ence blood-flow sample during each test condition. A fluid-filled
pressure-monitoring catheter (24-gauge Angiocath; Becton Dickinson,
Sandy, Utah) was inserted into the right radial artery.
The animal was anticoagulated with a bolus injection of heparin (300 U/
kg) and subsequent small boluses of heparin tomaintain an activated clotting
time of greater than 300 seconds. An IABP catheter (5 or 7 mL; Datascope,
Fairfield, NJ) was inserted via a left femoral artery cut down and advancedThe Journal of Thoracic and Caruntil the tip was distal to the left subclavian artery, as confirmed by digital
palpation. Balloon timing was manually adjusted with the arterial pressure
waveform (fluid-filled radial artery catheter or aortic root Millar catheter)
displayed on the IABP console (System 97; Datascope). Balloon inflation
anddeflationwere timed tomaximize aortic diastolic pressure augmentation
and minimize aortic end-diastolic pressure (afterload).
Induction of Ischemic Left Ventricular Failure
Intravenous lidocaine (20-mg bolus, 20-mg/h infusion) and esmolol
(5-mg/kg bolus, 50-mg/kg per minute infusion) were administered to
prevent arrhythmia. Sequential coronary ligation of branches of the LAD
induced acute ischemic left ventricular failure. Target cardiac dysfunction
was achieved when 3 of 4 criteria were met: approximate reduction of (1)
left ventricular cardiac output by 25%, (2) mean aortic pressure by 10 mm
Hg, (3) mixed venous O2 saturation by 10%, and (4) an elevation of left
atrial pressure (LAP) and/or left ventricular end-diastolic pressure by 5
mm Hg. Animals with life-threatening hypotension were supported with
boluses of intravenous normal saline and continuous infusion of phenyl-
ephrine and/or epinephrine to effect.
Blood Gas Analysis
During each experimental test condition, blood samples were simulta-
neously withdrawn from the coronary sinus, pulmonary artery, and right ca-
rotid artery. Samples were processed with a blood gas analyzer (IRMASL
Blood Analysis System; Diametrics Medical, Roseville, Minn) to measure
hemoglobin content ([Hb] g/dL) and hemoglobin oxygen saturation (%O2
Sat). Oxygen content ([O2]) was calculated for each blood sample:
½O2 ¼%O2Sat3½Hb3O2capacity of Hb ð1:34 ml O2=gÞ
100
¼ ½mL O2=100 mL
Total myocardial oxygen consumption (MVO2) was calculated as
follows:
MVO2 ¼
½O2a
½O2cs

3MBF ¼ ½mL=min=g
[O2]a ¼ arterial oxygen content, [O2]cs ¼ coronary sinus oxygen content,
MBF ¼ total myocardial blood flow in mL/min/100 g as determined by
the microsphere method.
End-Organ Blood Flow Measurements
During each experimental test condition, a different color (isotope label)
of 15-mmneutron-activated microspheres (13 106 microspheres in 0.4-mL
suspension; Biopal, Worcester, Mass) was injected into the left atrium, fol-
lowed by a 4-mL saline flush. The microsphere technique enabled the mea-
surement of regional end-organ blood flow in vascular beds of interest, as
previously described.4,5 During microsphere injection, a reference blood-
flow sample was drawn from the femoral artery at a rate of 4 mL/min for
60 seconds with a calibrated syringe pump (Harvard Apparatus, Holliston,
Mass). The withdrawal sample acted as a reference to determine organ-
specific flows in mL/min per gram of tissue.4
Necropsy and Microsphere Analysis
After completion of the experimental protocol, animals were euthanized
with an increase in anesthetic depth and an intravenous bolus injection of
supersaturated KCl. After euthanasia, the heart was harvested and weighed.
The ventricles were dissected from the atria. The left ventricle was
dissected from the right ventricle. The brain, lungs, kidneys, pancreas,
liver, spleen, and adrenals were harvested and weighed.
Tissue and reference blood samples were sent to BioPAL, Inc (Worcester,
Mass) for radioactive assay and automated calculation of blood flow in mL/
min per gram for each sample during each experimental test condition. Tissue
and blood sampleswere bombardedwith neutrons to transiently activate eachdiovascular Surgery c Volume 147, Number 5 1661
TABLE 1. Hemodynamic measurements in a pediatric model of left ventricular failure during IABP support
Variable
HR,
bpm
LADFmean,
mL/min
LVCO,
L/min
AoPmean,
mm Hg
LAPmean,
mm Hg
LVPend-diastolic,
mm Hg
L kidney,
mL/min
per gram
Mixed
venous
O2,%
Baseline 107  4 26  4 2.30  0.17 67  4 9  1 9  1 1.69  0.29 86  1
LV failure 104  3 16  3* 1.67  0.15* 53  3* 12  1* 14  1* 0.90  0.13* 70  4*
1:1 low-fidelity IABP 105  3 18  3 1.78  0.15 56  3 11  1 14  1 0.99  0.22 74  4
1:1 high-fidelity IABP 107  3 19  3 1.84  0.15 56  3 11  1 12  2 1.01  0.15 70  5
HR, Heart rate; bpm, beats per minute; LADF, left anterior descending coronary artery flow; LVCO, left ventricular cardiac output; AoP, aortic pressure; LAP, left atrial pressure;
LVP, left ventricular pressure; L, left; LV, left ventricular; IABP, intra-aortic balloon pump. *P<.05 versus baseline.
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detected in the sample was directly proportional to the number of micro-
spheres present in the sample. The activity of microspheres in the reference
blood samplewas comparedwith the activity ofmicrospheres that lodged in a
tissue sample of interest. The ratio between the 2 activity counts was equal to
the ratio between the calibrated rate of aortic withdrawal (known, 4 mL/min)
and flow in the tissue of interest (unknown).
Instrumentation, Data Reduction, and Statistics
All transducers were precalibrated and postcalibrated against known
physical standards to ensure measurement accuracy. Collected data were
signal conditioned (10003 gain and 60-Hz low-pass filter) and analog-FIGURE 1. A, Aortic root pressurewaveforms from the same animal demonstr
(middle panel) and 1:1 (bottom panel) intra-aortic balloon pump (IABP) suppo
Diastolic augmentation of greater than 20 mm Hg was achieved when the IABP
high-fidelity (micromanometer) catheter in the aorta. AoP, Aortic pressure; LV,
1662 The Journal of Thoracic and Cardiovascular Surto-digital converted at a sampling rate of 400 Hz for digital analysis using
our Good Laboratory Practices–compliant data acquisition system.6
Hemodynamic parameters were calculated on a beat-to-beat basis for
each 15-second data set with the Hemodynamic Evaluation and Assess-
ment Research Tool program7 developed in Matlab, version 6.5 (Math-
Works, Natick, Mass). All analyzed beats in each data set
(approximately 25-30 beats/15-second data set) were averaged to obtain
a single representative mean value for each calculated parameter.
Pressure and flow waveforms were used to derive the following hemo-
dynamic parameters: heart rate, aortic pressure (AoP), left atrial pressure
(LAP), left ventricular pressure (LVP), aortic flow (AoF), carotid artery
flow, and LAD flow (LADF). Left ventricular myocardial blood flow, asated suprasystolic diastolic augmentation and afterload reduction during 1:2
rt compared with baseline (top panel). Arrows indicate supported beats. B,
was timed with a low-fidelity (fluid-filled) catheter in the radial artery or a
left ventricular. *P<.0001 versus baseline; yP<.0001 versus LV failure.
gery c May 2014
FIGURE 2. A, End-diastolic aortic pressure (AoP) was significantly reduced during 1:1 intra-aortic balloon pump (IABP) therapy timed with a low-fidelity
(fluid-filled) catheter in the radial artery or a high-fidelity (micromanometer) catheter in the aorta. B, Left ventricular myocardial blood flow (LVF) did not
improve significantly during 1:1 IABP therapy timed with either a low-fidelity or a high-fidelity blood pressure signal. C, Myocardial oxygen consumption
(MVO2) did not improve during 1:1 IABP therapy timed with either a low-fidelity or a high-fidelity blood pressure signal. D, LVF normalized to MVO2, an
index of the myocardial oxygen supply/demand relationship, did not significantly improve during 1:1 IABP therapy timed with either a low-fidelity or a
high-fidelity blood pressure signal. LV, Left ventricular. *P<.01 versus baseline; †P<.05 versus LV failure.
Bartoli et al Evolving Technology/Basic Science
E
T
/B
Sdetermined by microspheres normalized to MVO2 was used as an index of
the oxygen supply/demand relationship.
Prism, version 4.00 (GraphPad, La Jolla, Calif), was used to perform
statistical analyses and to plot data. To verify the induction of a clinically
relevant state of left ventricular failure, paired Student t tests were used to
compare values for LADF, AoF, AoP, mixed venous O2 saturation,
end-organ blood flows, LAP, and LVP at baseline and after coronary
ligation. A 1-way repeated-measures analysis of variance with a Tukey
posttest for comparison of means was performed to compare left
ventricular failure and IABP timing modes (low and high fidelity) for
each parameter. P< .05 (95% confidence) was considered statistically
significant. All data were presented as mean  SE.RESULTS
Model of Pediatric Left Ventricular Failure
Of the 19 piglets, 10 completed the experimental proto-
col. In these animals, LAD ligation produced ischemic
left ventricular failure with phenotypic similarities to clin-
ical left ventricular failure (Table 1). Animals exhibited
an approximate reduction in LADFmean by 40% (26  4
to 16  3 mL/min, P< .01), AoF by 30% (2.4  0.2 to
1.7  0.2 L/min, P<.001), AoPmean by 15 mm Hg (67 
4 to 53  3 mm Hg, P<.01), mixed venous O2 saturation
by 15% (86% 1% to 70% 4%, P<.001), renal bloodThe Journal of Thoracic and Carflow by 45% to 50% (left kidney: 1.69  0.29 to 0.90 
0.13 mL/min per 100 g, P< .05; right kidney: 2.13 
0.45 to 1.02  0.18 mL/min per 100 g, P < .05), an
increased LAP by approximately 3 mm Hg (9  1 to 12
 1, P < .001), and LVPend-diastolic by approximately 5
mm Hg (9  1 to 14  1, P<.01).
The other 9 animals died before completion of the study
protocol, typically from intractable arrhythmia. Data from
these animals were not included in any of the analyses.Diastolic Augmentation and Left Ventricular
Afterload Reduction
At heart rates of 105  3 beats per minute (bpm; range,
83-125 bpm), it was possible to achieve statistically signi-
ficant suprasystolic diastolic pressure augmentation during
each native cardiac beat (Figure 1, A, bottom waveform).
During 1:1 IABP support timed with a low-fidelity (fluid-
filled) or a high-fidelity (micromanometer) blood pressure
signal, similar aortic pressure augmentation of greater
than 20 mm Hg was observed (Figure 1, B, P<.0001).
Significant left ventricular afterload reduction, as indi-
cated by aortic end-diastolic pressure, was also achieveddiovascular Surgery c Volume 147, Number 5 1663
FIGURE 3. A, Hemodynamic waveforms from the same animal during intra-aortic balloon pump (IABP) support demonstrated suprasystolic diastolic
augmentation and afterload reduction (top panel). Rapid balloon deflation and the decrease in end-diastolic blood pressure produced aortic, carotid, and
left anterior descending (LAD) coronary artery flow reversal. Arrows indicate periods of flow reversal. Waveforms show 1:2 IABP support to illustrate
that flow reversal is not present with unsupported beats. B, Aortic flow (AoF) reversal increased significantly during 1:1 IABP support. C, Carotid flow
(CarotidF) reversal increased significantly during 1:1 IABP support. D, LAD flow (LADF) increased significantly during 1:1 IABP support. B-D, Flow
reversal was not attenuated in any artery during 1:1 IABP therapy timed with a low-fidelity (fluid-filled) catheter in the radial artery or a high-fidelity
(micromanometer) catheter in the aorta. AoP, Aortic pressure; LV, left ventricular. *P<.01 versus baseline; yP<.05 versus LV failure.
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During 1:1 IABP support, aortic end-diastolic pressure
decreased by approximately 8 mmHg (left ventricular failure,
41 2mmHg; low-fidelity signal, 34 3mmHg [P<.0001];
high-fidelity signal, 33 3 mmHg [P<.0001]). The increase
in left ventricular myocardial blood flow during IABP support
was small and did not reach statistical significancewith either a
low- or high-fidelity blood pressure signal (Figure 2, B).
Similarly, myocardial oxygen consumption did not change
during 1:1 IABP support with either a low- or high-fidelity
blood pressure signal (Figure 2, C). As a result, despite
suprasystolic diastolic augmentation and left ventricular after-
load reduction, the myocardial oxygen supply/demand rela-
tionship did not significantly improve with either aTABLE 2. End-organ blood flow in a pediatric model of left ventricular fa
ANOVA
P value
L cerebrum,
mL/min
per gram
R cerebrum,
mL/min
per gram
Cer
m
pe
Baseline 0.31  0.08 0.28  0.07 0.6
Left ventricular failure 0.26  0.05 0.24  0.04 0.3
1:1 low-fidelity IABP 0.36  0.09 0.35  0.07 0.3
1:1 high-fidelity IABP 0.33  0.07 0.30  0.06 0.4
ANOVA, Analysis of variance; L, left; R, right; IABP, intra-aortic balloon pump. *P<.05
1664 The Journal of Thoracic and Cardiovascular Surlow-fidelity or a high-fidelity signal to adjust IABP inflation
and deflation timing (Figure 2, D).
Systemic Flow Reversal
Brief, but statistically significant, end-diastolic flow
reversal occurred in the aorta, carotid artery, and LAD
(Figure 3). During 1:1 IABP support, mean flow reversal
in the aorta increased by approximately 40 mL/min (left
ventricular failure, 65  10 mL/min; low-fidelity signal,
97  12 mL/min [P<.0001]; high-fidelity signal, 111
 12mL/min [P<.0001]). Mean flow reversal in the carotid
artery increased by approximately 15 mL/min (left ventric-
ular failure, 3  2 mL/min; low-fidelity signal, 19  3
mL/min [P< .0001]; high-fidelity signal, 20  3 mL/ilure during IABP support
ebellum,
L/min
r gram
Brainstem,
mL/min
per gram
L lung,
mL/min
per gram
R lung,
mL/min
per gram
2  0.08 0.42  0.10 1.99  0.48 2.51  0.76
5  0.03* 0.39  0.08 0.96  0.20* 0.98  0.21*
8  0.06 0.28  0.08 1.14  0.27 1.02  0.29
3  0.06 0.38  0.11 1.16  0.24 1.14  0.23
versus baseline.
gery c May 2014
Bartoli et al Evolving Technology/Basic Science
E
T
/B
Smin [P<.0001]). Mean flow reversal in the LAD increased
by approximately 0.70 mL/min (left ventricular failure,
0.24  0.06 mL/min; low-fidelity signal, 1.01  0.24
mL/min [P< .0001]; high-fidelity signal, 0.91  0.18
mL/min [P<.0001]).
End-Organ Blood Flow
Cardiac output (LVCO) did not significantly improve
during 1:1 IABP support (left ventricular failure,
1.67  0.15 L/min; low-fidelity signal, 1.78  0.15
L/min; high-fidelity signal, 1.84 0.15 L/min). As a result,
systemic end-organ blood flow did not significantly
improve with 1:1 IABP support timed with a low- or a
high-fidelity blood pressure signal (Table 2).
DISCUSSION
Pediatric patients with life-threatening heart failure pre-
sent difficult clinical challenges. During the past 5 decades,
the intra-aortic balloon pump (IABP) has successfully sup-
ported pediatric patients with congenital and acquired heart
disease as a bridge to decision, cardiac transplantation, and
recovery. Yet, mortality rates greater than 35%2,8,9 and the
lowest long-term survival for any pediatric mechanical
circulatory support modality10 indicate a need to improve
the efficacy of pediatric IABP therapy.
In this study, in a piglet model of acute left ventricular
failure, 1:1 IABP counterpulsationwas possible at high heart
rates. However, brief systemic blood flow reversal coincident
with IABP deflation may have limited the efficacy of IABP
support. Despite significant suprasystolic diastolic augmen-
tation and significant left ventricular afterload reduction
during 1:1 IABP support, left ventricular myocardial blood
flow, myocardial oxygen consumption, and the myocardial
oxygen supply/demand relationship did not improve.
Cardiac output and end-organ blood flow also did not
significantly improve. A brief, but significant, flow reversal
in conduit arteries may have limited systemic forward flow.
Traditional IABP inflation and deflation timing with a
high-fidelity trigger did not attenuate flow reversal or
improve IABP efficacy. These findings suggest that end-
diastolic flow reversal is an important and novel mechanism
that may limit the efficacy of IABP counterpulsation in pedi-
atric patients with traditional inflation and deflation criteria.L kidney,
mL/min
per gram
R kidney,
mL/min
per gram
Pancreas,
mL/min
per gram
Live
mL/m
per gr
1.69  0.31 2.13  0.45 0.29  0.08 0.52 
0.90  0.13* 1.02  0.18* 0.22  0.05 0.21 
0.99  0.22 1.02  0.20 0.20  0.04 0.23 
1.01  0.15 1.20  0.18 0.19  0.04 0.36 0
TABLE 2. Continued
The Journal of Thoracic and CarClinical Considerations
The optimal timing of pediatric IABP inflation and defla-
tion is uncertain.11,12 In any patient with an IABP, it is
traditionally thought that inflation and deflation of the
balloon must occur during diastole between closure of the
aortic valve and the subsequent systole. In an adult patient,
this timing paradigm typically is not difficult to achieve.
However, pediatric patients have higher heart rates than
adults (newborn, 120-160 bpm; infant/toddler, 90-130
bpm), and diastole is short. As heart rate increases, diastole
becomes disproportionally shorter.13 As a result, inflation
and deflation of the balloon must occur within a smaller win-
dow of time. From the current study, we speculate that the
short duration of diastole during high heart rates may limit
the hemodynamic benefits of IABP inflation. Correspond-
ingly, rapid balloon deflation produces a sharp reduction in
aortic end-diastolic blood pressure and brief flow reversal suf-
ficient to limit net augmentation of coronary blood flow or
improve the myocardial oxygen supply/demand relationship.
Indeed, in adult patients, balloon deflation may produce a
steep reduction of central end-diastolic blood pressure that
may lead to a ‘‘steal’’ phenomenon during which coro-
nary,14,15 carotid,15,16 cerebral,17 and aortic15,18 blood
flow reverse. In adults, flow reversal is brief, and net flow
augmentation is still positive. However, in a pediatric
patient with a high heart rate, forward flow from diastolic
augmentation occurs over a shorter period, and rapid
balloon deflation occurs more frequently. As a result, the
ratio between flow reversal and augmented forward flow
is greater and may limit maximum net forward flow.
Importantly, coronary flow reversal may be attenuated by
adjusting inflation and deflation timing.14 In adults with a
normal heart rate (60-80 bpm), sufficient time exists be-
tween each systole to allow a brief (up to 25-millisecond)
deflation delay, which may reduce flow reversal. As a result,
subtle variations in the timing of inflation and deflation may
permit an incremental tradeoff between afterload and
myocardial workload reduction versus diastolic augmenta-
tion and coronary perfusion. Unfortunately, in pediatric
patients, high heart rates with a shorter diastole minimize
the available window to delay deflation for this tradeoff.
Similarly, brief timing errors associated with a fluid-filled
versus a high-fidelity signal12 or a high-fidelity signal versusr,
in
am
Spleen,
mL/min
per gram
L adrenal,
mL/min
per gram
R adrenal,
mL/min
per gram
0.20 1.14  0.22 0.88  0.33 0.83  0.35
0.06 0.41  0.07* 0.41  0.04 0.39  0.08
0.05 0.50  0.15 0.56  0.11 0.52  0.12
.08 0.54  0.09 0.62  0.14 0.63  0.13
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efficacy in pediatric patients. A precise signal is required
to accurately time inflation and deflation and maximize
counterpulsation efficacy in pediatric patients. To this end,
integration of a high-fidelity micromanometer into the cath-
eter tip may eliminate timing error(s), especially compared
with low-fidelity fluid-filled catheters, which introduce gain
and phase distortion and tend to drift over time.20 Indeed,
we19 observed that it was easier to identify inflation and
deflation timing landmarks in the arterial pressurewaveform
acquired with a high-fidelity signal. Consequently, timing
errors were unlikely responsible for end-diastolic flow
reversal. In our study, adjustment of IABP timing with a
high-fidelity blood pressure signal (that minimized timing
error) did not significantly reduce end-diastolic flow
reversal or improve hemodynamics or end-organ blood
flow compared with a low-fidelity signal. This finding
further supports the notion that balloon inflation and defla-
tion with traditional timing criteria triggered by a high-
fidelity arterial blood pressure signal are insufficient to
improve counterpulsation therapy in pediatric patients.
Instead, the development of alternative timing strategies
are necessary to prevent end-diastolic flow reversal and
improve IABP efficacy in pediatric patients.
Other Considerations
Counterpulsation therapy is most effective when the dis-
placed blood volume of the balloon and the left ventricular
stroke volume are similar.21,22 In this study, we used 5- and
7-mL IABPs, which are the clinically recommended sizes
for an 8- to 18-kg infant.23 However, the stroke volume of
a 12-kg piglet (and a 12-kg human) with left ventricular fail-
ure is approximately 15 to 17 mL, more than 3 times the
displacement volume of these IABPs. This observation
begs the question of whether a larger balloon (and a larger
displaced blood volume) may produce greater diastolic
pressure augmentation to significantly improve diastolic
coronary blood flow. By the same token, rapid deflation of
a balloon with a larger volume may produce a greater
decrease in end-diastolic aortic blood pressure and further
increase the volume of blood flow reversal. This hypothesis
remains untested. However, from a technical standpoint, the
size of peripheral arteries in pediatric patients may limit the
size of the balloon catheter that may be safely inserted and
preclude counterpulsation therapy with a larger-sized IABP.
Arterial compliance also plays an important role in coun-
terpulsation therapy. It has been demonstrated in vitro,24
experimentally in animal studies,25 and clinically26 that
the efficacy of counterpulsation therapy correlates inversely
with arterial compliance. Specifically, stiffer arteries
generate the greatest diastolic augmentation and reduction
in end-diastolic blood pressure. As a result, it has been spec-
ulated that the high compliance of the pediatric aorta may
limit IABP efficacy.27 This effect has not been rigorously1666 The Journal of Thoracic and Cardiovascular Surdefined. Moreover, there is evidence to the contrary that
the compliance of the pediatric aorta28 is sufficient to pro-
duce diastolic augmentation, afterload reduction, and
improved hemodynamics.27 Our results further support
this point.Future Investigations
Ongoing studies will determine whether alternative
timing strategies, such as delayed balloon deflation, may
improve the efficacy of pediatric counterpulsation. Simi-
larly, the use of larger pediatric balloons with greater
displacement volumes that are more comparable to native
stroke volume may improve the efficacy of pediatric
IABP counterpulsation.CONCLUSIONS
An incomplete understanding of counterpulsation has
limited the widespread application of IABPs in pediatric
patients. In a piglet model of acute ischemic left ventricular
failure, significant diastolic augmentation and afterload
reduction were achieved with a pediatric IABP at high heart
rates. However, significant aortic, carotid, and coronary
blood flow reversal, coincident with balloon deflation
during end diastole, reduced net systemic forward flow.
IABP inflation and deflation timed with traditional criteria
and a high-fidelity blood pressure signal did not attenuate
flow reversal or improve IABP efficacy. These findings
suggest that brief end-diastolic flow reversal is an important
and novel mechanism that may limit the effectiveness of
IABP counterpulsation in pediatric patients with traditional
inflation and deflation criteria.
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